These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12563360)

  • 21. Nonmalignant complications of therapy for Hodgkin's disease.
    Hohl RJ; Schilsky RL
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):331-43. PubMed ID: 2663831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
    Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
    Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
    Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity of a combination of ABVD chemotherapy and mediastinal irradiation for Hodgkin's disease patients with massive initial mediastinal involvement.
    Lagrange JL; Thyss A; Caldani C; Héry M; Schneider M; Bensadoun JR
    Bull Cancer; 1988; 75(8):801-6. PubMed ID: 2460169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy.
    Tsai HR; Gjesdal O; Wethal T; Haugaa KH; Fosså A; Fosså SD; Edvardsen T
    Am J Cardiol; 2011 Feb; 107(3):472-7. PubMed ID: 21257017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe valvular toxicity and pericarditis early after radiation therapy in a patient treated for Hodgkin's lymphoma.
    Ramyar A; Shafiei M; Moazzami K; Rezaei N
    Turk J Pediatr; 2010; 52(4):423-5. PubMed ID: 21043392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.
    Adams MJ; Lipsitz SR; Colan SD; Tarbell NJ; Treves ST; Diller L; Greenbaum N; Mauch P; Lipshultz SE
    J Clin Oncol; 2004 Aug; 22(15):3139-48. PubMed ID: 15284266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermediate stage Hodgkin's disease: preliminary results on 210 patients treated with four ABVD chemotherapy cycles plus extended versus involved field radiotherapy.
    Anselmo AP; Cavalieri E; Osti FM; Cantonetti M; De Sanctis V; Alfo M; Amadori S; Enrici RM
    Anticancer Res; 2004; 24(6):4045-50. PubMed ID: 15736450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The incidence and treatment of the first relapse in children with Hodgkin's disease].
    Balwierz W; Moryl-Bujakowska A; Bogusławska-Jaworska J; Pisarek J; Raś M; Sońta-Jakimczyk D; Janik-Moszant A; Rokicka-Milewska R; Sopylo B; Kolakowska-Mrozowska B; Kołecki P; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Matysiak M; Newecka-Samól T
    Med Wieku Rozwoj; 2000; 4(1 Suppl 2):73-84. PubMed ID: 12021465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic pericarditis in Hodgkin disease].
    Miltényi Z; Gergely L; Illés A
    Orv Hetil; 2002 Dec; 143(48):2687-9. PubMed ID: 12501578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
    Engert A; Schiller P; Josting A; Herrmann R; Koch P; Sieber M; Boissevain F; De Wit M; Mezger J; Duhmke E; Willich N; Muller RP; Schmidt BF; Renner H; Muller-Hermelink HK; Pfistner B; Wolf J; Hasenclever D; Loffler M; Diehl V;
    J Clin Oncol; 2003 Oct; 21(19):3601-8. PubMed ID: 12913100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes of the Heart Valves in the Long Term After Chemoradiotherapy According to Different Protocols for Hodgkin's Lymphoma in Children and Adolescents.
    Parkhomenko RA; Shcherbenko OI; Rybakova MK; Zelinskaya NI; Kharchenko NV; Kunda MA; Zapirov GM
    J Adolesc Young Adult Oncol; 2019 Aug; 8(4):410-416. PubMed ID: 31017511
    [No Abstract]   [Full Text] [Related]  

  • 34. [Second neoplasms in Hodgkin's disease].
    Cebreiros I; Ordóñez A; García de Paredes ML; Vicente J; Martín G; González Barón M
    Rev Clin Esp; 1989 Mar; 184(5):247-8. PubMed ID: 2772295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
    De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
    Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late pulmonary toxicity after treatment for Hodgkin's disease.
    Villani F; De Maria P; Bonfante V; Viviani S; Laffranchi A; Dell'oca I; Dirusso A; Zanini M
    Anticancer Res; 1997; 17(6D):4739-42. PubMed ID: 9494599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies.
    Schellong G; Riepenhausen M; Bruch C; Kotthoff S; Vogt J; Bölling T; Dieckmann K; Pötter R; Heinecke A; Brämswig J; Dörffel W
    Pediatr Blood Cancer; 2010 Dec; 55(6):1145-52. PubMed ID: 20734400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
    N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of radiotherapy in the treatment of Hodgkin's disease].
    Saito Y; Hirose J; Chohtoh S; Nishijima H; Kobayashi A; Kamimura R; Takashima T; Ohtake S; Yoshida T; Nakamura S
    Gan No Rinsho; 1985 Dec; 31(15):1899-904. PubMed ID: 3841562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.